Altitude sickness explained

Altitude sickness
Field:Emergency medicine
Synonyms:High-altitude sickness, altitude illness, hypobaropathy, altitude bends, soroche
Symptoms:Headache, vomiting, feeling tired, trouble sleeping, dizziness
Complications:High-altitude pulmonary edema (HAPE),
high-altitude cerebral edema (HACE)
Onset:Within 24 hours
Types:Acute mountain sickness, high-altitude pulmonary edema, high-altitude cerebral edema, chronic mountain sickness
Causes:Low amounts of oxygen at high elevation
Risks:Prior episode, high degree of activity, rapid increase in elevation
Diagnosis:Based on symptoms
Differential:Exhaustion, viral infection, hangover, dehydration, carbon monoxide poisoning
Prevention:Gradual ascent
Treatment:Descent to lower altitude, sufficient fluids
Medication:Ibuprofen, acetazolamide, dexamethasone, oxygen therapy
Frequency:20% at 2500m (8,200feet)
40% at 3000m (10,000feet)

Altitude sickness, the mildest form being acute mountain sickness (AMS), is a harmful effect of high altitude, caused by rapid exposure to low amounts of oxygen at high elevation.[1] [2] People can respond to high altitude in different ways. Symptoms may include headaches, vomiting, tiredness, confusion, trouble sleeping, and dizziness. Acute mountain sickness can progress to high-altitude pulmonary edema (HAPE) with associated shortness of breath or high-altitude cerebral edema (HACE) with associated confusion.[1] Chronic mountain sickness may occur after long-term exposure to high altitude.[1]

Altitude sickness typically occurs only above 2500m (8,200feet), though some are affected at lower altitudes.[1] Risk factors include a prior episode of altitude sickness, a high degree of activity, and a rapid increase in elevation.[1] Diagnosis is based on symptoms and is supported for those who have more than a minor reduction in activities.[1] [3] It is recommended that at high altitude any symptoms of headache, nausea, shortness of breath, or vomiting be assumed to be altitude sickness.[4]

Sickness is prevented by gradually increasing elevation by no more than 300m (1,000feet) per day. Being physically fit does not decrease the risk.[1] Generally, descent and sufficient fluid intake can treat symptoms.[1] Mild cases may be helped by ibuprofen, acetazolamide, or dexamethasone.[1] Severe cases may benefit from oxygen therapy and a portable hyperbaric bag may be used if descent is not possible.[5] Treatment efforts, however, have not been well studied.[6]

AMS occurs in about 20% of people after rapidly going to 2500m (8,200feet) and in 40% of people after going to 3000m (10,000feet).[5] [1] While AMS and HACE occurs equally frequently in males and females, HAPE occurs more often in males.[5] The earliest description of altitude sickness is attributed to a Chinese text from around 30 BCE that describes "Big Headache Mountains", possibly referring to the Karakoram Mountains around Kilik Pass.[7]

Signs and symptoms

People have different susceptibilities to altitude sickness; for some otherwise healthy people, acute altitude sickness can begin to appear at around above sea level, such as at many mountain ski resorts, equivalent to a pressure of 80kPa.[8] This is the most frequent type of altitude sickness encountered. Symptoms often manifest within ten hours of ascent and generally subside within two days, though they occasionally develop into the more serious conditions. Symptoms include headache, confusion, fatigue, stomach illness, dizziness, and sleep disturbance.[9] Exertion may aggravate the symptoms.

Those individuals with the lowest initial partial pressure of end-tidal pCO2 (the lowest concentration of carbon dioxide at the end of the respiratory cycle, a measure of a higher alveolar ventilation) and corresponding high oxygen saturation levels tend to have a lower incidence of acute mountain sickness than those with high end-tidal pCO2 and low oxygen saturation levels.[10]

Primary symptoms

Headaches are the primary symptom used to diagnose altitude sickness, although a headache is also a symptom of dehydration. A headache occurring at an altitude above a pressure of 76kPacombined with any one or more of the following symptoms, may indicate altitude sickness:

Disordered systemSymptoms
GastrointestinalLoss of appetite, nausea, vomiting, excessive flatulation
NervousFatigue or weakness, headache with or without dizziness or lightheadedness, insomnia, "pins and needles" sensation
LocomotoryPeripheral edema (swelling of hands, feet, and face)
RespiratoryNose bleeding, shortness of breath upon exertion
CardiovascularPersistent rapid pulse
OtherGeneral malaise

Severe symptoms

Symptoms that may indicate life-threatening altitude sickness include:

Pulmonary edema (fluid in the lungs)
  • Symptoms similar to bronchitis
  • Persistent dry cough
  • Fever
  • Shortness of breath even when resting
    Cerebral edema (swelling of the brain)
  • Headache that does not respond to analgesics
  • Unsteady gait
  • Gradual loss of consciousness
  • Increased nausea and vomiting
  • Retinal hemorrhage

    The most serious symptoms of altitude sickness arise from edema (fluid accumulation in the tissues of the body). At very high altitude, humans can get either high-altitude pulmonary edema (HAPE), or high-altitude cerebral edema (HACE). The physiological cause of altitude-induced edema is not conclusively established. It is currently believed, however, that HACE is caused by local vasodilation of cerebral blood vessels in response to hypoxia, resulting in greater blood flow and, consequently, greater capillary pressures. On the other hand, HAPE may be due to general vasoconstriction in the pulmonary circulation (normally a response to regional ventilation-perfusion mismatches) which, with constant or increased cardiac output, also leads to increases in capillary pressures. For those with HACE, dexamethasone may provide temporary relief from symptoms in order to keep descending under their own power.

    HAPE can progress rapidly and is often fatal. Symptoms include fatigue, severe dyspnea at rest, and cough that is initially dry but may progress to produce pink, frothy sputum. Descent to lower altitudes alleviates the symptoms of HAPE.

    HACE is a life-threatening condition that can lead to coma or death. Symptoms include headache, fatigue, visual impairment, bladder dysfunction, bowel dysfunction, loss of coordination, paralysis on one side of the body, and confusion. Descent to lower altitudes may save those affected by HACE.

    Cause

    See also: Effects of high altitude on humans. Altitude sickness can first occur at 1500m (4,900feet), with the effects becoming severe at extreme altitudes (greater than 5500m (18,000feet)). Only brief trips above 6000m (20,000feet) are possible and supplemental oxygen is needed to avert sickness.

    As altitude increases, the available amount of oxygen to sustain mental and physical alertness decreases with the overall air pressure, though the relative percentage of oxygen in air, at about 21%, remains practically unchanged up to 21000m (69,000feet).[11] The RMS velocities of diatomic nitrogen and oxygen are very similar and thus no change occurs in the ratio of oxygen to nitrogen until stratospheric heights.

    Dehydration due to the higher rate of water vapor lost from the lungs at higher altitudes may contribute to the symptoms of altitude sickness.[12]

    The rate of ascent, altitude attained, amount of physical activity at high altitude, as well as individual susceptibility, are contributing factors to the onset and severity of high-altitude illness.

    Altitude sickness usually occurs following a rapid ascent and can usually be prevented by ascending slowly.[9] In most of these cases, the symptoms are temporary and usually abate as altitude acclimatization occurs. However, in extreme cases, altitude sickness can be fatal.

    High altitude illness can be classified according to the altitude: high (1500m–3500mm (4,900feet–11,500feetm)), very high (3500m–5500mm (11,500feet–18,000feetm)) and extreme (above 5500m (18,000feet)).[13]

    High altitude

    At high altitude, 1500mto3500mm (4,900feetto11,500feetm), the onset of physiological effects of diminished inspiratory oxygen pressure (PiO2) includes decreased exercise performance and increased ventilation (lower arterial partial pressure of carbon dioxide: PCO2). While arterial oxygen transport may be only slightly impaired the arterial oxygen saturation (SaO2) generally stays above 90%. Altitude sickness is common between 2400mand4000mm (7,900feetand13,000feetm) because of the large number of people who ascend rapidly to these altitudes.[14]

    Very high altitude

    At very high altitude, 3500mto5500mm (11,500feetto18,000feetm), maximum SaO2 falls below 90% as the arterial PO2 falls below 60mmHg. Extreme hypoxemia may occur during exercise, during sleep, and in the presence of high altitude pulmonary edema or other acute lung conditions. Severe altitude illness occurs most commonly in this range.[14]

    Extreme altitude

    Above 5500m (18,000feet), marked hypoxemia, hypocapnia, and alkalosis are characteristic of extreme altitudes. Progressive deterioration of physiologic function eventually outstrips acclimatization. As a result, no permanent human habitation occurs above . A period of acclimatization is necessary when ascending to extreme altitude; abrupt ascent without supplemental oxygen for other than brief exposures invites severe altitude sickness.[14]

    Mechanism

    The physiology of altitude sickness centres around the alveolar gas equation; the atmospheric pressure is low, but there is still 20.9% oxygen. Water vapour still occupies the same pressure too—this means that there is less oxygen pressure available in the lungs and blood. Compare these two equations comparing the amount of oxygen in blood at altitude:[15]

    At Sea LevelAt 8400 m (The Balcony of Everest)Formula
    Pressure of oxygen in the alveolus21\% \times(101.3\text-6.3\text) - \left (\frac \right) = 13.3 \text_221\% \times(36.3\text-6.3\text) - \left (\frac \right) = 3.9 \text_2F_I \text_2 \times(P_\text-P_) - \left (\frac \right)
    Oxygen Carriage in the blood\left(0.98 \times 1.34 \times 14\frac\right) + (0.023\times 12\text) = \frac\left(0.54 \times 1.34 \times 19.3\frac\right) + (0.023\times 3.3\text) = \frac(\text_\times 1.34\tfrac \times \text) +(\text_2\text \times \text_)
    The hypoxia leads to an increase in minute ventilation (hence both low, and subsequently bicarbonate), Hb increases through haemoconcentration and erythrogenesis. Alkalosis shifts the haemoglobin dissociation constant to the left, 2,3-BPG increases to counter this. Cardiac output increases through an increase in heart rate.

    The body's response to high altitude includes the following:

    People with high-altitude sickness generally have reduced hyperventilator response, impaired gas exchange, fluid retention or increased sympathetic drive. There is thought to be an increase in cerebral venous volume because of an increase in cerebral blood flow and hypocapnic cerebral vasoconstriction causing oedema.

    Diagnosis

    Altitude sickness is typically self-diagnosed since symptoms are consistent: nausea, vomiting, headache, and can generally be deduced from a rapid change in altitude or oxygen levels. However, some symptoms may be confused with dehydration. Some severe cases may require professional diagnosis which can be assisted with multiple different methods such as using an MRI or CT scan to check for abnormal buildup of fluids in the lung or brain.[3] [16]

    Prevention

    Ascending slowly is the best way to avoid altitude sickness.[9] Avoiding strenuous activity such as skiing, hiking, etc. in the first 24 hours at high altitude may reduce the symptoms of AMS. Alcohol and sleeping pills are respiratory depressants, and thus slow down the acclimatization process and should be avoided. Alcohol also tends to cause dehydration and exacerbates AMS. Thus, avoiding alcohol consumption in the first 24–48 hours at a higher altitude is optimal.

    Pre-acclimatization

    Pre-acclimatization is when the body develops tolerance to low oxygen concentrations before ascending to an altitude. It significantly reduces risk because less time has to be spent at altitude to acclimatize in the traditional way. Additionally, because less time has to be spent on the mountain, less food and supplies have to be taken up. Several commercial systems exist that use altitude tents, so called because they mimic altitude by reducing the percentage of oxygen in the air while keeping air pressure constant to the surroundings. Examples of pre-acclimation measures include remote ischaemic preconditioning, using hypobaric air breathing in order to simulate altitude, and positive end-expiratory pressure.

    Altitude acclimatization

    Altitude acclimatization is the process of adjusting to decreasing oxygen levels at higher elevations, in order to avoid altitude sickness.[17] Once above approximately 3000m (10,000feet)a pressure of 70kPamost climbers and high-altitude trekkers take the "climb-high, sleep-low" approach. For high-altitude climbers, a typical acclimatization regimen might be to stay a few days at a base camp, climb up to a higher camp (slowly), and then return to base camp. A subsequent climb to the higher camp then includes an overnight stay. This process is then repeated a few times, each time extending the time spent at higher altitudes to let the body adjust to the oxygen level there, a process that involves the production of additional red blood cells.[18] Once the climber has acclimatized to a given altitude, the process is repeated with camps placed at progressively higher elevations. The rule of thumb is to ascend no more than 300m (1,000feet) per day to sleep. That is, one can climb from 3000m (10,000feet) (70abbr=onNaNabbr=on) to 4500m (14,800feet) (58abbr=onNaNabbr=on) in one day, but one should then descend back to 3300m (10,800feet) (67.5abbr=onNaNabbr=on) to sleep. This process cannot safely be rushed, and this is why climbers need to spend days (or even weeks at times) acclimatizing before attempting to climb a high peak. Simulated altitude equipment such as altitude tents provide hypoxic (reduced oxygen) air, and are designed to allow partial pre-acclimation to high altitude, reducing the total time required on the mountain itself.

    Altitude acclimatization is necessary for some people who move rapidly from lower altitudes to higher altitudes.[19]

    Medications

    The drug acetazolamide (trade name Diamox) may help some people making a rapid ascent to sleeping altitude above 2700m (8,900feet), and it may also be effective if started early in the course of AMS.[20] Acetazolamide can be taken before symptoms appear as a preventive measure at a dose of 125 mg twice daily. The Everest Base Camp Medical Centre cautions against its routine use as a substitute for a reasonable ascent schedule, except where rapid ascent is forced by flying into high altitude locations or due to terrain considerations.[21] The Centre suggests a dosage of 125 mg twice daily for prophylaxis, starting from 24 hours before ascending until a few days at the highest altitude or on descending;[21] with 250 mg twice daily recommended for treatment of AMS.[22] The Centers for Disease Control and Prevention (CDC) suggest the same dose for prevention of 125 mg acetazolamide every 12 hours.[23] Acetazolamide, a mild diuretic, works by stimulating the kidneys to secrete more bicarbonate in the urine, thereby acidifying the blood. This change in pH stimulates the respiratory center to increase the depth and frequency of respiration, thus speeding the natural acclimatization process. An undesirable side-effect of acetazolamide is a reduction in aerobic endurance performance. Other minor side effects include a tingle-sensation in hands and feet. Although a sulfonamide, acetazolamide is a non-antibiotic and has not been shown to cause life-threatening allergic cross-reactivity in those with a self-reported sulfonamide allergy.[24] [25] [26] Dosage of 1000 mg/day will produce a 25% decrease in performance, on top of the reduction due to high-altitude exposure.[27] The CDC advises that Dexamethasone be reserved for treatment of severe AMS and HACE during descents, and notes that Nifedipine may prevent HAPE.[23]

    There is insufficient evidence to determine the safety of sumatriptan and if it may help prevent altitude sickness.[28] Despite their popularity, antioxidant treatments have not been found to be effective medications for prevention of AMS.[29] Interest in phosphodiesterase inhibitors such as sildenafil has been limited by the possibility that these drugs might worsen the headache of mountain sickness.[30] A promising possible preventive for altitude sickness is myo-inositol trispyrophosphate (ITPP), which increases the amount of oxygen released by hemoglobin.

    Prior to the onset of altitude sickness, ibuprofen is a suggested non-steroidal anti-inflammatory and painkiller that can help alleviate both the headache and nausea associated with AMS. It has not been studied for the prevention of cerebral edema (swelling of the brain) associated with extreme symptoms of AMS.[31]

    Over-the-counter herbal supplements and traditional medicines

    Herbal supplements and traditional medicines are sometimes suggested to prevent high altitude sickness including ginkgo biloba, R crenulata, minerals such as iron, antacids, and hormonal-based supplements such as medroxyprogesterone and erythropoietin. Medical evidence to support the effectiveness and safety of these approaches is often contradictory or lacking. Indigenous peoples of the Americas, such as the Aymaras of the Altiplano, have for centuries chewed coca leaves to try to alleviate the symptoms of mild altitude sickness. This therapy has not yet been proven effective in a clinical study.[32] In Chinese and Tibetan traditional medicine, an extract of the root tissue of Radix rhodiola is often taken in order to prevent the symptoms of high altitude sickness, however, no clear medical studies have confirmed the effectiveness or safety of this extract.[33]

    Oxygen enrichment

    In high-altitude conditions, oxygen enrichment can counteract the hypoxia related effects of altitude sickness. A small amount of supplemental oxygen reduces the equivalent altitude in climate-controlled rooms. At (67abbr=onNaNabbr=on), raising the oxygen concentration level by 5% via an oxygen concentrator and an existing ventilation system provides an effective altitude of 3000m (10,000feet) (70abbr=onNaNabbr=on), which is more tolerable for those unaccustomed to high altitudes.[34]

    Oxygen from gas bottles or liquid containers can be applied directly via a nasal cannula or mask. Oxygen concentrators based upon pressure swing adsorption (PSA), VSA, or vacuum-pressure swing adsorption (VPSA) can be used to generate the oxygen if electricity is available. Stationary oxygen concentrators typically use PSA technology, which has performance degradations at the lower barometric pressures at high altitudes. One way to compensate for the performance degradation is to use a concentrator with more flow capacity. There are also portable oxygen concentrators that can be used on vehicular DC power or on internal batteries, and at least one system commercially available measures and compensates for the altitude effect on its performance up to 4000m (13,000feet). The application of high-purity oxygen from one of these methods increases the partial pressure of oxygen by raising the FiO2 (fraction of inspired oxygen).

    Other methods

    Increased water intake may also help in acclimatization[35] to replace the fluids lost through heavier breathing in the thin, dry air found at altitude, although consuming excessive quantities ("over-hydration") has no benefits and may cause dangerous hyponatremia.

    Treatment

    The only reliable treatment, and in many cases the only option available, is to descend. Attempts to treat or stabilize the patient in situ (at altitude) are dangerous unless highly controlled and with good medical facilities. However, the following treatments have been used when the patient's location and circumstances permit:

    See also

    External links

    Notes and References

    1. Web site: Altitude Diseases – Injuries; Poisoning . Merck Manuals Professional Edition . 3 August 2018 . May 2018.
    2. Book: Rose . Stuart R. . CHAPTER 15 – Altitude Illness . 1 January 2006 . https://www.sciencedirect.com/science/article/pii/B9780323040501500201 . International Travel Health Guide 2006-2007 . 216–229 . Rose . Stuart R. . Philadelphia . Mosby . en . 978-0-323-04050-1. Keystone . Jay S. . Connor . Bradley A. . Hackett . Peter . Kozarsky . Phyllis E. . Quarry . Doug . Keystone . Jay S. . Connor . Bradley A. . Hackett . Peter . Thirteenth . 11 October 2022 . https://web.archive.org/web/20221011143411/https://www.sciencedirect.com/science/article/pii/B9780323040501500201 . live.
    3. Meier D, Collet TH, Locatelli I, Cornuz J, Kayser B, Simel DL, Sartori C . Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review . . 318 . 18 . 1810–1819 . November 2017 . 29136449 . 10.1001/jama.2017.16192 . 205087288.
    4. Book: A Comprehensive Guide to Wilderness & Travel Medicine . 3rd . Weiss E . 2005 . 978-0-9659768-1-7 . Altitude Illness . 137–141 . Adventure Medical Kits . The Golden Rules of Altitude Illness 1) Above 8,000 feet, headache, nausea, shortness of breath, and vomiting should be considered to be altitude illness until proven otherwise. 2) No one with mild symptoms of altitude illness should ascend any higher until symptoms have resolved. 3) Anyone with worsening symptoms or severe symptoms of altitude illness should descend immediately to a lower altitude..
    5. Book: Ferri FF . Ferri's Clinical Advisor 2017 E-Book: 5 Books in 1 . 2016 . Elsevier Health Sciences . 9780323448383 . 590 . en.
    6. Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, Franco JV, Xu Y, Hidalgo R . Interventions for treating acute high altitude illness . The Cochrane Database of Systematic Reviews . 6 . CD009567 . June 2018 . 12 . 29959871 . 6513207 . 10.1002/14651858.CD009567.pub2.
    7. Book: West JB . High Life: A History of High-Altitude Physiology and Medicine . 2013 . Springer . 9781461475736 . 2–7 . en.
    8. Web site: K. . Baillie . A. . Simpson . Acute mountain sickness . Apex (Altitude Physiology Expeditions) . 8 August 2007 . https://web.archive.org/web/20100201060010/http://www.altitude.org/high_altitude.php . 1 February 2010 . dead.  — High altitude information for laypeople
    9. Web site: A. A. R. . Thompson . Altitude Sickness . Apex . 8 May 2007.
    10. Douglas DJ, Schoene RB . End-tidal partial pressure of carbon dioxide and acute mountain sickness in the first 24 hours upon ascent to Cusco Peru (3326 meters) . . 21 . 2 . 109–13 . June 2010 . 20591371 . 10.1016/j.wem.2010.01.003 . free.
    11. FSF Editorial Staff . Wheel-well Stowaways Risk Lethal Levels of Hypoxia and Hypothermia . . 2 . 44 . 3 . May–June 1997 . . 28 October 2010 . The relative amount of oxygen in the air (21 percent) does not vary appreciably at altitudes up to 21,350 meters (70,000 feet). . https://web.archive.org/web/20101128161251/http://flightsafety.org/hf/hf_may-jun97.pdf . 28 November 2010 . live.
    12. Hackett PH, Roach RC . High-altitude illness . . 345 . 2 . 107–14 . July 2001 . 11450659 . 10.1056/NEJM200107123450206.
    13. Molano Franco D, Nieto Estrada VH, Gonzalez Garay AG, Martí-Carvajal AJ, Arevalo-Rodriguez I . Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions . The Cochrane Database of Systematic Reviews . 4 . 4 . CD013315 . April 2019 . 31012483 . 6477878 . 10.1002/14651858.CD013315.
    14. Book: Auerbach P . Paul Auerbach . Wilderness Medicine . Mosby Elsevier . 5th . 2007 . 978-0-323-03228-5 . Auer07.
    15. Brown JP, Grocott MP . 2013-02-01 . Humans at altitude: physiology and pathophysiology . Continuing Education in Anaesthesia, Critical Care & Pain . 13 . 1 . 17–22 . 10.1093/bjaceaccp/mks047 . 1743-1816 . free.
    16. Web site: What Is Altitude Sickness? . 2021-07-02 . . en.
    17. Muza . S.R. . Fulco . C.S. . Cymerman . A. . Altitude Acclimatization Guide . U.S. Army Research Inst. Of Environmental Medicine Thermal and Mountain Medicine Division Technical Report . USARIEM–TN–04–05 . 2004 . 5 March 2009 . https://web.archive.org/web/20090423042451/http://archive.rubicon-foundation.org/7616 . 23 April 2009 . usurped.
    18. Book: Tortora GJ, Anagnostakos NP . Principles of anatomy and physiology . registration . 444–445. Fifth . New York . Harper & Row, Publishers . 1987 . 978-0-06-350729-6.
    19. Web site: Altitude Illness . . Telluride, Colorado.
    20. Book: . International travel and health . Chapter 3: Environmental health risks . http://whqlibdoc.who.int/publications/2007/9789241580397_3_eng.pdf . 31 . 1 January 2007 . 21 November 2009.
    21. Web site: Prophylaxis . Everest BC Clinic, BaseCampMD.com . 21 November 2009.
    22. Web site: Treating AMS . Everest BC Clinic, BaseCampMD.com . 21 November 2009.
    23. Book: CDC Health Information for International Travel 2010 "The Yellow Book" . Turell D, Brunette G, Kozarsky P, Lefor A . Chapter 2 The Pre-Travel Consultation – Self-Treatable Diseases – Altitude Illness . Hackett P, Shlim D . http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/altitude-illness.aspx . Mosby . St. Louis . 2009 . 978-0-7020-3481-7. registration .
    24. Platt D, Griggs RC . Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies . . 69 . 4 . 527–9 . April 2012 . 22158718 . 3785308 . 10.1001/archneurol.2011.2723.
    25. Kelly TE, Hackett PH . Acetazolamide and sulfonamide allergy: a not so simple story . . 11 . 4 . 319–23 . 2010 . 21190500 . 10.1089/ham.2010.1051.
    26. Lee AG, Anderson R, Kardon RH, Wall M . Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? . . 138 . 1 . 114–8 . July 2004 . 15234289 . 10.1016/j.ajo.2004.02.019 .
    27. Web site: Altitude Acclimatization Guide . dead . https://web.archive.org/web/20120324235011/http://www.usariem.army.mil/Pages/download/altitudeacclimatizationguide.pdf . 24 March 2012.
    28. Gonzalez Garay . Alejandro . Molano Franco . Daniel . Nieto Estrada . Víctor H. . Martí-Carvajal . Arturo J. . Arevalo-Rodriguez . Ingrid . March 2018 . Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs . The Cochrane Database of Systematic Reviews . 3 . 12 . CD012983 . 10.1002/14651858.CD012983 . 1469-493X . 6494375 . 29529715.
    29. Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, Maxwell SR, Webb DJ . 6 . Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial . . 102 . 5 . 341–8 . May 2009 . 19273551 . 10.1093/qjmed/hcp026 . free.
    30. Bates MG, Thompson AA, Baillie JK . Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema . Current Opinion in Investigational Drugs . 8 . 3 . 226–31 . March 2007 . 17408118.
    31. Web site: Ibuprofen decreases likelihood of altitude sickness, researchers find . John . Sanford . March 2012 . 19 September 2012 . https://web.archive.org/web/20120424180422/http://med.stanford.edu/ism/2012/march/altitude.html . 24 April 2012 . dead.
    32. Bauer I . Erythroxylum – a comprehensive review . . 5 . 1 . 20 . 2019-11-26 . 31798934 . 6880514 . 10.1186/s40794-019-0095-7 . free .
    33. Wang J, Xiong X, Xing Y, Liu Z, Jiang W, Huang J, Feng B . Chinese herbal medicine for acute mountain sickness: a systematic review of randomized controlled trials . . 2013 . 732562 . 2013 . 24454510 . 3881533 . 10.1155/2013/732562 . free.
    34. West JB . Oxygen enrichment of room air to relieve the hypoxia of high altitude . Respiration Physiology . 99 . 2 . 225–32 . February 1995 . 7777705 . 10.1016/0034-5687(94)00094-G.
    35. Book: Dannen K, Dannen D . Rocky Mountain National Park . Globe Pequot . 2002 . 9 . 978-0-7627-2245-7 . Visitors unaccustomed to high elevations may experience symptoms of Acute Mountain Sickness (AMS)[...s]uggestions for alleviating symptoms include drinking plenty of water[.] . Google Books.
    36. Cain SM, Dunn JE . Low doses of acetazolamide to aid accommodation of men to altitude . . 21 . 4 . 1195–200 . July 1966 . 5916650 . 10.1152/jappl.1966.21.4.1195.
    37. Grissom CK, Roach RC, Sarnquist FH, Hackett PH . Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange . . 116 . 6 . 461–5 . March 1992 . 1739236 . 10.7326/0003-4819-116-6-461. 1731172 .
    38. Lipman GS, Kanaan NC, Holck PS, Constance BB, Gertsch JH . Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories . . 59 . 6 . 484–90 . June 2012 . 22440488 . 10.1016/j.annemergmed.2012.01.019.
    39. Gertsch JH, Corbett B, Holck PS, Mulcahy A, Watts M, Stillwagon NT, Casto AM, Abramson CH, Vaughan CP, Macguire C, Farzan NN, Vo BN, Norvelle RJ, May K, Holly JE, Irons H, Stutz AM, Chapagain P, Yadav S, Pun M, Farrar J, Basnyat B . 6 . Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness . . 23 . 4 . 307–15 . December 2012 . 23098412 . 10.1016/j.wem.2012.08.001 . free.
    40. Kanaan NC, Peterson AL, Pun M, Holck PS, Starling J, Basyal B, Freeman TF, Gehner JR, Keyes L, Levin DR, O'Leary CJ, Stuart KE, Thapa GB, Tiwari A, Velgersdyk JL, Zafren K, Basnyat B . 6 . Prophylactic Acetaminophen or Ibuprofen Results in Equivalent Acute Mountain Sickness Incidence at High Altitude: A Prospective Randomized Trial . en . . 28 . 2 . 72–78 . June 2017 . 28479001 . 10.1016/j.wem.2016.12.011 . free.